Lonza Readies Phosphatidylserine Line

April 20, 2012

Lonza Group Ltd. (Basel, Switzerland) has officially launched Memree, the company’s new line of phosphatidylserine (PS) products.

Lonza Group Ltd. (Basel, Switzerland) has officially launched Memree, the company’s new line of phosphatidylserine (PS) products. The company anticipated product launches last year, when the company entered into a partnership with PS developer Lipogen Ltd. (Haifa, Israel).

PS is a cognitive health ingredient that has shown potential to improve memory, concentration, and learning in human clinical trials. PS is the only ingredient authorized for a qualified FDA health claim for cognitive dysfunction and dementia in the elderly.

The Memree PS product line includes MemreePS and MemreePlus, a combination of PS and phosphatidic acid that has demonstrated potential to reduce active levels of cortisol, a hormone associated with stress.

Lonza holds rights to market the phosphatidylserine ingredient in food, beverage, supplement, and medical food forms.